Age-dependent systemic antibody responses and immunisation-associated changes in mice orally and nasally immunised with Lactococcus lactis expressing a malaria parasite protein

Vaccine

Volumn 27, Issue 36, 2009, Pages 4947-4952

  Moorthy, S A V ^a   Yasawardena, S G ^b   Ramasamy, R ^c  

^a NATIONAL SCIENCE FOUNDATION   (Sri Lanka)

^b UNIVERSITY OF SRI JAYEWARDENEPURA   (Sri Lanka)

^c UNIVERSITI BRUNEI DARUSSALAM   (Brunei Darussalam)

Author keywords

Food grade bacteria; Gut histology; Lactococcus; Mucosal immunisation; Nasal immunisation; Oral immunisation; Plasmodium falciparum; Vaccine vectors; Vaccines

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; MEROZOITE SURFACE ANTIGEN 2; PEPTIDOGLYCAN; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL CELL WALL; CONTROLLED STUDY; COVALENT BOND; DRUG DELIVERY SYSTEM; ILEUM; IMMUNIZATION; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN BLOOD LEVEL; LACTOCOCCUS LACTIS; LAMINA PROPRIA; LYMPH FOLLICLE; LYMPHOID TISSUE; MEROZOITE; MESENTERY LYMPH NODE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; AGE FACTORS; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BACTERIAL VACCINES; GENETIC VECTORS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTOCOCCUS LACTIS; MALARIA VACCINES; MALARIA, FALCIPARUM; MICE; MICE, INBRED BALB C; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; VACCINES, SYNTHETIC;

EID: 67650578290     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.011     Document Type: Article

References (38)

1. Weiner H.L., Friedman A., Miller A., Khoury S.J., Al-Sabbagh A., Santos L., et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune disease by oral administration of autoantigens. Annu Rev Immunol 12 (1994) 809-837
2. Blum S., Alvarez S., Haller D., Perez P., and Soniffrin E.J. Intestinal microflora and the interaction with immunocompetent cells. Antonie van Leeuwenhoek 76 (1999) 199-205
3. Mestecky J., and Eldridge J.H. Targetting and controlled release of antigens for the effective induction of secretary antibody responses. Curr Opin Immunol 3 (1991) 492-495
4. O'Hagan D.T. Novel delivery systems for oral vaccines (1994), CRC Press, FL
5. Dahlgren U.I.H., Wold A.E., Hanson L.A., and Midtvedt T. Expression of a dietary protein in E. coli renders it strongly antigenic to gut lymphoid tissue. Immunology 73 (1991) 394-397
6. Moss B. Genetically engineered poxviruses for recombinant gene expression, vaccination and safety. Proc Natl Acad Sci USA 93 (1996) 11341-11348
7. Wold A.E., Dahlgren U.I.H., Hanson L.A., Mattsby-Baltzer I., and Midvetdt T. Difference between bacterial and food antigens in mucosal immunogenicity. Infect Immun 57 (1989) 2666-2673
8. Tamura S., Ito Y., Asmuma H., Hirabayashi Y., Suzuki Y., Nagamine T., et al. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J Immun 149 (1992) 981-988
9. Hashigucci K., Ogawa H., Ishidate T., Yamashita R., Kamiya H., Watanabe K., et al. Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin. Vaccine 14 (1996) 113-119
10. Wilschut J., de Haan A., Geerligs H.J., Huchshorn J.P., van Scharrenburg G.J.M., Palache A.M., et al. Liposomes as a mucosal adjuvant system: an intranasal liposomal influenza subunit vaccine and the role of IgA in nasal anti-influenza immunity. J Liposome Res 4 (1994) 301-314
11. Mercenier A., Muller-Alouf H., and Grangette C. Lactic acid bacteria as live vaccines. Curr Issues Mol Biol 2 (2000) 17-25
12. Dougan G., Roberts M., Douce G., Londono P., Hormaeche C., Harrison J., et al. The genetics of Salmonella and vaccine development. In: Hormaeche C.F., Mastroeni P., and Bonina L. (Eds). Biology of Salmonella (1993), Plenum Press
13. Yasutomi Y., Koenig S., Haun S.S., Stover C.K., Jackson R.K., Conard P., et al. Immunisation with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J Immunol 150 (1993) 3101-3107
14. Ryan E.T., Butterton J.R., Smith R.N., Carroll P.A., Crean T.I., and Calderwood S.B. Protective immunity against Clostridium difficile toxin A induced by oral immunisation with a live, attenuated Vibrio cholerae vector strain. Infect Immun 65 (1997) 2941-2949
15. Kelly W.J., Davey G.P., and Ward L.J. Characterization of lactococci isolated from minimally processed fresh fruit and vegetables. Int J Food Microbiol 45 2 (1998) 85-92
16. Wells J.M., Wilson P.W., Norton P.M., Gasson M.J., and Le Page R.W.F. Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol Microbiol 8 (1993) 1155-1162
17. Robinson K., Chamberlain L.M., Lopez M.C., Rush C.M., Marcotte H., Le Page R.W.F., et al. Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infect Immun 72 (2004) 2753-2761
18. Bermudez-Humaran L.G., Cortes-Perez N.G., Lefevre F., Guimaraes V., Rabot S., Alcocer-Gonzalez J.M., et al. A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J Immunol 175 (2005) 7297-7302
19. Ramasamy R., Yasawardene S.G., Zomer A., Venema G., Kok J., and Leenhouts K. Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations. Vaccine 24 (2006) 3900-3908
20. Audouy S.A.L., van Selm S., van Roosmalen M.L., Post E., Kanninga R., Neef J., et al. Development of lactococcal GEM-based pneumococcal vaccines. Vaccine 25 (2007) 2497-2506
21. Hanniffy S.B., Carter A.T., Hitchin E., and Wells J.M. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J Infect Dis 195 (2007) 184-193
22. Moorthy G., and Ramasamy R. Mucosal immunisation of mice with malaria protein on lactic acid bacterial cell walls. Vaccine 25 18 (2007) 3636-3645
23. Genton B., Betuela I., Felger I., Al-Yaman F., Anders R.F., Saul A., et al. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis 185 (2002) 820-827
24. Al-Yaman F., Genton B., Reeder J.C., Mokela D., Anders R.F., and Alpers M.P. Humoral response to defined Plasmodium falciparum antigens in cerebral and uncomplicated malaria and their relationship to parasite genotype. Am J Trop Med Hyg 56 (1997) 430-435
25. Epping R.J., Goldstone S.D., Ingram L.T., Upcroft J.A., Ramasamy R., Cooper J.A., et al. Geysen HMAn epitope recognised by inhibitory monoclonal antibodies that react with a 51 kilodalton merozoite surface antigen in Plasmodium falciparum. Mol Biochem Parasitol 28 (1988) 1-10
26. Ramasamy R., Jones G., and Lord R. Characterisation of an inhibitory monoclonal antibody defined epitope on a malaria vaccine candidate antigen. Immunol Lett 23 (1990) 305-310
27. Ramasamy R., Yasawardena S.G., Kanagaratnam R., Buratti E., Baralle F.E., and Ramasamy M.S. Mammalian cell expression of malaria merozoite surface proteins and experimental DNA and RNA immunisation. Biochim Biophys Acta 1453 (1999) 1-13
28. Adkins B., Leclerc C., and Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 4 (2004) 553-564
29. Pawelec G., Barnett Y., Forsey R., Frasca D., Globerson A., McLeod J., et al. T cells and aging, January 2002 update. Front Biosci 7 (2002) 1056-1183
30. Grubeck-Loebenstein B. Changes in the aging immune system. Biologicals 25 (1997) 205-208
31. Linton P.J., and Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 5 (2004) 133-139
32. Ramasamy R., and Rajakaruna R. Association of malaria with α-1-3-galactosyl transferase inactivation in catarrhines. Biochim Biophys Acta 1360 (1997) 241-246
33. Frasca D., Van der Put E., Richard L.R., and Bonnie B.B. Reduced Ig class switch in aged mice correlates with decreased E47 and activation-induced cytidine deaminase. J Immunol 172 (2004) 2155-2162
34. Forchielli M.L., and Walker W.A. The role of gut-associated lymphoid tissues and mucosal defense. Brit J Nutr 93 Suppl. 1 (2005) S41-S48
35. Vesa T., Pochart P., and Marteau P. Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract. Aliment Pharmacol Ther 14 6 (2000) 823-828
36. Drouault S., Corthier G., Ehrlich S.D., and Renault P. Survival, physiology and lysis of Lactococcus lactis in the digestive tract. Appl Environ Microbiol 65 (1999) 4881-4886
37. Kimoto H., Nomura M., Kobayashi M., Mizumachi K., and Okamoto T. Survival of lactococci during passage through mouse digestive tract. Can J Microbiol 49 (2003) 707-711
38. Bouskra D., Brezillon C., Berard M., Werts C., Varona R., Boneca I.V., et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456 (2008) 507-512